Orpro Therapeutics Inc.

San Diego, CA

UEI
DMFYKL5PQLF3
CAGE
5KUB1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
12670 High Bluff Dr, San Diego, CA 92130, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Orpro Therapeutics Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Engineered monothiol thioredoxin for treatment of radiation induced lung injury - abstract this project aims to evaluate… Grant · R41HL180185 National Heart Lung and Blood Institute $508,988
Development of monothiol human thioredoxin-1 (ORP100S) as an inhaled treatment for acute viral lung injury Grant · W81XWH2210613 Defense Health Agency $4,294,046
Mucoadhesive drug conjugates for controlled-release inhalation delivery Grant · R43HL142395 National Heart Lung and Blood Institute $226,781
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis Grant · R44HL140735 National Institutes of Health $1,724,117
Development of human thioredoxin as a mucolytic therapy for cystic fibrosis Grant · R43HL114132 National Institutes of Health $183,089

Quick answers

What is Orpro Therapeutics Inc.'s UEI?

Orpro Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is DMFYKL5PQLF3.

What is Orpro Therapeutics Inc.'s CAGE code?

Orpro Therapeutics Inc.'s CAGE code is 5KUB1.

Where is Orpro Therapeutics Inc. located?

Orpro Therapeutics Inc.'s physical address in SAM.gov is 12670 High Bluff Dr, San Diego, CA 92130, USA.

Is Orpro Therapeutics Inc. registered in SAM.gov?

Yes. Orpro Therapeutics Inc.'s SAM.gov registration is active through December 3, 2026.

What is Orpro Therapeutics Inc.'s most recent federal award?

Orpro Therapeutics Inc.'s most recent federal grant award is Engineered monothiol thioredoxin for treatment of radiation induced lung injury - abstract this project aims to evaluate… (R41HL180185), from National Heart Lung and Blood Institute, on September 24, 2025.

On GovTribe

See Orpro Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login